Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients

OBJECTIVES: To address whether the use of methotrexate (MTX) and biological disease-modifying anti-rheumatic drugs (bDMARDs) impacts bone structure and biomechanical properties in patients with psoriatic arthritis (PsA). METHODS: This is a cross-sectional study in PsA patients receiving no DMARDs, M...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, David, Kleyer, Arnd, Bayat, Sara, Tascilar, Koray, Kampylafka, Eleni, Meinderink, Timo, Schuster, Louis, Petrov, Ramona, Liphardt, Anna-Maria, Rech, Juergen, Schett, Georg, Hueber, Axel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607518/
https://www.ncbi.nlm.nih.gov/pubmed/31269973
http://dx.doi.org/10.1186/s13075-019-1938-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607518/
https://www.ncbi.nlm.nih.gov/pubmed/31269973
http://dx.doi.org/10.1186/s13075-019-1938-3

Ejemplares similares